Renaissance Technologies - PLIANT THERAPEUTICS INC ownership

PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 78 filers reported holding PLIANT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PLIANT THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,676
+814.4%
138,200
+564.4%
0.01%
+400.0%
Q4 2022$402
-100.0%
20,800
-77.9%
0.00%
-66.7%
Q3 2022$1,970,000
+134.0%
94,300
-10.3%
0.00%
+200.0%
Q2 2022$842,000
+13.8%
105,100
-0.5%
0.00%0.0%
Q1 2022$740,000
+80.9%
105,600
+248.4%
0.00%0.0%
Q4 2021$409,000
-19.2%
30,307
+1.0%
0.00%0.0%
Q3 2021$506,00030,0000.00%
Other shareholders
PLIANT THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TRV GP III, LLC 339,160$5,881,034100.00%
CHI Advisors LLC 3,014,199$52,266,21120.72%
TRV GP IV, LLC 2,132,867$36,983,91413.93%
GREAT POINT PARTNERS LLC 1,755,184$30,434,8915.54%
First Light Asset Management, LLC 2,933,260$50,862,7284.83%
Deep Track Capital, LP 5,500,000$95,370,0003.68%
Casdin Capital, LLC 1,577,108$27,347,0533.03%
Fernwood Investment Management, LLC 379,702$6,584,0332.37%
Redmile Group, LLC 2,678,099$46,438,2372.21%
SILVERARC CAPITAL MANAGEMENT, LLC 250,409$4,342,0921.32%
View complete list of PLIANT THERAPEUTICS INC shareholders